全文获取类型
收费全文 | 4259篇 |
免费 | 282篇 |
国内免费 | 119篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 218篇 |
妇产科学 | 120篇 |
基础医学 | 849篇 |
口腔科学 | 53篇 |
临床医学 | 351篇 |
内科学 | 794篇 |
皮肤病学 | 55篇 |
神经病学 | 249篇 |
特种医学 | 45篇 |
外国民族医学 | 1篇 |
外科学 | 412篇 |
综合类 | 466篇 |
现状与发展 | 2篇 |
预防医学 | 318篇 |
眼科学 | 102篇 |
药学 | 335篇 |
中国医学 | 84篇 |
肿瘤学 | 173篇 |
出版年
2023年 | 47篇 |
2022年 | 73篇 |
2021年 | 127篇 |
2020年 | 118篇 |
2019年 | 182篇 |
2018年 | 201篇 |
2017年 | 143篇 |
2016年 | 160篇 |
2015年 | 170篇 |
2014年 | 254篇 |
2013年 | 271篇 |
2012年 | 203篇 |
2011年 | 298篇 |
2010年 | 225篇 |
2009年 | 218篇 |
2008年 | 250篇 |
2007年 | 189篇 |
2006年 | 197篇 |
2005年 | 171篇 |
2004年 | 179篇 |
2003年 | 129篇 |
2002年 | 95篇 |
2001年 | 79篇 |
2000年 | 76篇 |
1999年 | 65篇 |
1998年 | 44篇 |
1997年 | 37篇 |
1996年 | 30篇 |
1995年 | 39篇 |
1994年 | 36篇 |
1993年 | 40篇 |
1992年 | 34篇 |
1991年 | 27篇 |
1990年 | 32篇 |
1989年 | 31篇 |
1988年 | 20篇 |
1987年 | 18篇 |
1986年 | 8篇 |
1985年 | 21篇 |
1984年 | 20篇 |
1983年 | 10篇 |
1982年 | 22篇 |
1981年 | 12篇 |
1980年 | 11篇 |
1979年 | 9篇 |
1978年 | 5篇 |
1977年 | 7篇 |
1976年 | 10篇 |
1974年 | 6篇 |
1973年 | 3篇 |
排序方式: 共有4660条查询结果,搜索用时 46 毫秒
51.
Comparative Study of Distribution of Active Sites According to Their Stereospecificity in Propylene Polymerization over the Traditional TiCl3 and Supported Titanium–Magnesium Catalysts with Different Composition 下载免费PDF全文
Marina Nikolaeva Mikhail Matsko Vladimir Zakharov 《Macromolecular chemistry and physics.》2018,219(5)
The preparative‐temperature rising elution fractionation method is used to obtain comparative data on contents of fractions with different microtacticities for polypropylene (PP) samples prepared using three catalytic systems: the traditional Ziegler–Natta (Z–N) catalyst δ‐TiCl3 and two types of supported titanium–magnesium catalysts: the “donor‐free” TiCl4/MgCl2 catalyst and TiCl4/MgCl2·nDBP catalyst (DBP – dibutylphthalate used as an internal donor) at polymerization with the same cocatalyst (AlEt3) in the absence and presence of an external donor (propyltrimetoxy silane). The separated individual PP fractions are also studied by gel permeation chromatography (molecular weight and molecular weight distribution) and differential scanning calorimetry. The results demonstrate general regularities and differences in the formation of active sites having different isospecificities for the traditional TiCl3‐based Z–N catalyst and highly active supported titanium–magnesium catalysts. 相似文献
52.
Chun K.K. Ma Leighton Clancy Renee Simms Jane Burgess Shivashni Deo Emily Blyth Kenneth P. Micklethwaite David J. Gottlieb 《Biology of blood and marrow transplantation》2018,24(1):71-77
Adoptive cellular immunotherapy has been shown to be effective in the management of cytomegalovirus (CMV) reactivation and disease. Whether adjuvant dendritic cell (DC) vaccination will provide additional benefit in prophylaxis or treatment of CMV in hematoietic cell transplantation (HSCT) recipients is unknown. In this study, we administered prophylactic CMV-peptide specific T cell infusions, followed by 2 doses of intradermal CMV peptide-pulsed DC vaccine, to 4 HSCT recipients. There were no immediate adverse events associated with T cell infusion or DC vaccinations. One of the 4 patients developed grade III acute gut graft-versus-host disease. Immune reconstitution against CMV was detected in all 4 patients. Patients receiving CMV peptide-specific T cells and DC vaccination had peak immune reconstitution at least 10 days after the second DC vaccination. In summary, combining DC vaccine with T cell infusion appears feasible, although further study is required to ascertain its safety and efficacy in augmenting the effects of infusing donor-derived CMV-specific T cells. 相似文献
53.
Jose F. Camargo Erik Kimble Rossana Rosa Luis A. Shimose Maria X. Bueno Nikeshan Jeyakumar Michele I. Morris Lilian M. Abbo Jacques Simkins Maritza C. Alencar Cara Benjamin Eric Wieder Antonio Jimenez Amer Beitinjaneh Mark Goodman John J. Byrnes Lazaros J. Lekakis Denise Pereira Krishna V. Komanduri 《Biology of blood and marrow transplantation》2018,24(4):806-814
The optimal viral load threshold at which to initiate preemptive cytomegalovirus (CMV) therapy in hematopoietic cell transplantation (HCT) recipients remains to be defined. In an effort to address this question, we conducted a retrospective study of 174 allogeneic HCT recipients who underwent transplantation at a single center between August 2012 and April 2016. During this period, preemptive therapy was initiated at the discretion of the treating clinician. A total of 109 patients (63%) developed CMV viremia. The median time to reactivation was 17 days (interquartile range, IQR, 7-30 days) post-HCT. A peak viremia ≥150?IU/mL was strongly associated with a reduced probability of spontaneous clearance (relative risk, .16; 95% confidence interval, .1-.27), independent of established clinical risk factors, including CMV donor serostatus, exposure to antithymocyte globulin, and underlying lymphoid malignancy. The median time to clearance of viremia was significantly shorter in those who started therapy at CMV <350?IU/mL (19 days; IQR, 11-35 days) compared with those who started antiviral therapy at higher viremia thresholds (33 days; IQR, 21-42 days; P?=?.02). The occurrence of treatment-associated cytopenias was frequent but similar in patients who started preemptive therapy at CMV <350?IU/mL and those who started at CMV >350?IU/mL (44% versus 57%; P?=?.42). Unresolved CMV viremia by treatment day 35 was associated with increased risk of therapeutic failure (32% versus 0%; P?=?.001). Achieving eradication of CMV viremia by treatment day 35 was associated with a 74% reduction in 1-year nonrelapse mortality (NRM) (adjusted hazard ratio [HR], .26; 95% confidence interval [CI], .1-.8; P?=?.02), whereas therapeutic failure was associated with a significant increase in the probability of 1-year NRM (adjusted HR, 26; 95% CI, 8-87; P?<.0001). We conclude that among allogeneic HCT patients, a peak CMV viremia ≥150?IU/mL is associated with a >80% reduction in the probability of spontaneous clearance independent of ATG administration, CMV donor serostatus, and lymphoid malignancy, and is a reasonable cutoff for preemptive therapy. Delaying initiation of therapy until a CMV value ≥350?IU/mL is associated with more protracted CMV viremia, and unresolved viremia by treatment day 35 is associated with a significant increase in NRM. 相似文献
54.
A. John Barrett Susan Prockop Catherine M. Bollard 《Biology of blood and marrow transplantation》2018,24(1):13-18
Virus infection remains an appreciable cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Although pharmacotherapy and/or antibody therapy may help prevent or treat viral disease, these drugs are expensive, toxic, and often ineffective due to primary or secondary resistance. Further, effective treatments are limited for many infections (eg, adenovirus, BK virus), which are increasingly detected after alternative donor transplants. These deficiencies in conventional therapeutics have increased interest in an immunotherapeutic approach to viral disorders, leading to adoptive transfer of virus-specific cytotoxic T lymphocytes (VSTs), which can rapidly reconstitute antiviral immunity post-transplantation without causing graft-versus-host disease. This review will explore how the VST field has improved outcomes for many patients with life-threatening viral infections after HSCT, and how to broaden applicability beyond the “patient-specific” products, as well as extending to other viral diseases even outside the context of HSCT. 相似文献
55.
Min Liu Hui Wang Jiaxiang Zhang Xiaodong Yang Bodong Li Changhao Wu 《Journal of immunotoxicology》2018,15(1):63-72
Both NF-κB pathway and complement activation appear to be involved in kidney damage induced by trichloroethylene (TCE). However, any relationship between these two systems has not yet been established. The present study aimed to clarify the role of NF-κB in complement activation and renal injury in TCE-sensitized BALB/c mice. Mice were sensitized by an initial subcutaneous injection and repeated focal applications of TCE to dorsal skin at specified timepoints. NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) was injected (intraperitoneal) before the final two focal TCE challenges. In the experiments, mice had their blood and kidneys collected. Kidney function was evaluated via blood urea nitrogen (BUN) and creatinine (Cr) content; renal histology was examined using transmission electron microscopy (TEM). Kidney levels of phospho-p65 were assessed by Western blot and kidney mRNA levels of interleukin (IL)-1β, IL-6, IL-17, tumor necrosis factor (TNF)-α, and p65 by real-time quantitative PCR. Presence of C3 and C5b-9 membrane attack complexes in the kidneys was evaluated via immunohistochemistry. The results showed there was significant swelling, vacuolar degeneration in mitochondria, shrinkage of microvilli, disappearance of brush borders, segmental foot process fusion, and glomerular basement membrane thickening (or disrobing) in kidneys from TCE-sensitized mice. In conjunction with these changes, serum BUN and Cr levels were increased and IL-1β, IL-6, IL-17, and TNFα mRNA levels were elevated. Levels of p65 and phospho-p65 protein were also up-regulated, and there was significant C3 and C5b-9 deposition. PDTC pretreatment attenuated TCE-induced up-regulation of p65 and its phosphorylation, complement deposition, cytokine release, and renal damage. These results provide the first evidence that NF-κB pathway has an important role in TCE-induced renal damage mediated by enhanced complement activation in situ. 相似文献
56.
57.
Mayu Shiomi Shinya Matsuzaki Satoshi Serada Koji Matsuo Chihiro Mizuta-Odani Mariko Jitsumori Ruriko Nakae Satoko Matsuzaki Satoshi Nakagawa Kosuke Hiramatsu Ai Miyoshi Eiji Kobayashi Toshihiro Kimura Yutaka Ueda Kiyoshi Yoshino Tetsuji Naka Tadashi Kimura 《Cancer science》2021,112(9):3655-3668
This study aimed to investigate the cytotoxicity of a cluster of differentiation 70 antibody-drug conjugate (CD70-ADC) against ovarian cancer in in vitro and in vivo xenograft models. CD70 expression was assessed in clinical samples by immunohistochemical analysis. Western blotting and fluorescence-activated cell sorting analyses were used to determine CD70 expression in the ovarian cancer cell lines A2780 and SKOV3, and in the cisplatin-resistant ovarian cancer cell lines A2780cisR and SKOV3cisR. CD70 expression after cisplatin exposure was determined in A2780 cells transfected with mock- or nuclear factor (NF)-κB-p65-small interfering RNA. We developed an ADC with an anti-CD70 monoclonal antibody linked to monomethyl auristatin F and investigated its cytotoxic effect. We examined 63 ovarian cancer clinical samples; 43 (68.3%) of them expressed CD70. Among patients with advanced stage disease (n = 50), those who received neoadjuvant chemotherapy were more likely to exhibit high CD70 expression compared to those who did not (55.6% [15/27] vs 17.4% [4/23], P < .01). CD70 expression was confirmed in A2780cisR, SKOV3, and SKOV3cisR cells. Notably, CD70 expression was induced after cisplatin treatment in A2780 mock cells but not in A2780-NF-κB-p65-silenced cells. CD70-ADC was cytotoxic to A2780cisR, SKOV3, and SKOV3cisR cells, with IC50 values ranging from 0.104 to 0.341 nmol/L. In A2780cisR and SKOV3cisR xenograft models, tumor growth in CD70-ADC treated mice was significantly inhibited compared to that in the control-ADC treated mice (A2780cisR: 32.0 vs 1639.0 mm3, P < .01; SKOV3cisR: 232.2 vs 584.9 mm3, P < .01). Platinum treatment induced CD70 expression in ovarian cancer cells. CD70-ADC may have potential therapeutic implications in the treatment of CD70 expressing ovarian cancer. 相似文献
58.
59.
Min Zhong Wan-ling Song Ye-chun Xu Yang Ye Lin-yin Feng 《Acta pharmacologica Sinica》2015,36(3):298-310
Aim:
Paeoniflorin from Chinese herb Paeoniae Radix has been shown to ameliorate middle cerebral artery occlusion-induced ischemia in rats. The aim of this study was to investigate the mechanisms underlying the neuroprotective action of PF in cultured rat cortical neurons.Methods:
Primary cultured cortical neurons of rats were subjected to oxygen-glucose deprivation and reoxygenation (OGD/R) insult. Cell survival was determined using MTT assay. HEK293 cells stably transfected with A1R (HEK293/A1R) were used for detailed analysis. Phosphorylation of the signaling proteins was evaluated by Western blot or immunoprecipitation. Receptor interactions were identified using co-immunoprecipitation and immunofluorescence staining.Results:
Paeoniflorin (10 nmol/L to 1 μmol/L) increased the survival of neurons subjected to OGD/R. Furthermore, paeoniflorin increased the phosphorylation of Akt and ERK1/2 in these neurons. These effects were blocked by PI3K inhibitor wortmannin or MEK inhibitor U0126. Paeoniflorin also increased the phosphorylation of Akt and ERK1/2 in HEK293/A1R cells. Both A1R antagonist DPCPX and EGFR inhibitor AG1478 not only blocked paeoniflorin-induced phosphorylation of ERK1/2 and Akt in HEK293/A1R cells, but also paeoniflorin-increased survival of neurons subjected to OGD/R. In addition, paeoniflorin increased the phosphorylation of Src kinase and activation of MMP-2 in HEK293/A1R cells. Both Src inhibitor PP2 and MMP-2/MMP-9 inhibitor BiPs not only blocked paeoniflorin-induced phosphorylation of ERK1/2 (and Akt) in HEK293/A1R cells, but also paeoniflorin-increased survival of neurons subjected to OGD/R.Conclusion:
Paeoniflorin promotes the survival of cultured cortical neurons by increasing Akt and ERK1/2 phosphorylation via A1R-mediated transactivation of EGFR. 相似文献60.
Klein F Feldhahn N Harder L Wang H Wartenberg M Hofmann WK Wernet P Siebert R Müschen M 《The Journal of experimental medicine》2004,199(5):673-685
The BCR-ABL1 kinase expressed in acute lymphoblastic leukemia (ALL) drives malignant transformation of human pre-B cells. Comparing genome-wide gene expression profiles of BCR-ABL1+ pre-B ALL and normal bone marrow pre-B cells by serial analysis of gene expression, many genes involved in pre-B cell receptor signaling are silenced in the leukemia cells. Although normal pre-B cells are selected for the expression of a functional pre-B cell receptor, BCR-ABL1+ ALL cells mostly do not harbor a productively rearranged IGH allele. In these cases, we identified traces of secondary VH gene rearrangements, which may have rendered an initially productive VH region gene nonfunctional. Even BCR-ABL1+ ALL cells harboring a functional VH region gene are unresponsive to pre-B cell receptor engagement and exhibit autonomous oscillatory Ca2+ signaling activity. Conversely, leukemia subclones surviving inhibition of BCR-ABL1 by STI571 restore responsiveness to antigen receptor engagement and differentiate into immature B cells expressing immunoglobulin light chains. BCR-ABL1 kinase activity is linked to defective pre-B cell receptor signaling and the expression of a truncated isoform of the pre-B cell receptor-associated linker molecule SLP65. Also in primary leukemia cells, truncated SLP65 is expressed before but not after treatment of the patients with STI571. We conclude that inhibition of BCR-ABL1 reconstitutes selection for leukemia cells expressing a functional (pre-) B cell receptor. 相似文献